Join our Symposium
📅 27th February 🕛 12:30 PM CET
📍 Room K1, Level -2
Chairperson: Prof. Andrea Laghi (Italy)
Speakers: Prof. Baptiste Morel (France),
Prof. Anna Pichiecchio (Italy)
Home of Innovations
Immerse yourself in the world of Guerbet, where innovation is at the heart of every activity. Discover how our pioneering spirit has shaped our history and continues to guide our future.
Come and join us at our booth during the ECR to discover our latest innovations in MRI and AI.
📅 27th February 🕛 12:30 PM CET
Join our Symposium
📅 28th February 🕛 12:30 PM CET
📍 Room 01, Level 1
Chairperson: Prof. Harriet Thoeny
Speakers: Dr. Jean-Sebastien Raynaud,
Dr. Sarah Catoen, Dr. Eric Lancelot
Main activities
ECR Studio Interviews
Wednesday 26 February 2025 : 10:15 to 10:45 AM CET with our SVPs Philippe Bourrinet and Dan Raffi.
JT de la Radiologie
Don't miss 4 interviews of Guerbet leaders at "JT de la Radiologie" during the ECR 2025.
Join us at The CUBE !
Discover Interactive Sessions, Simulator Adventure Park, Expert Guidance & Networking Opportunities.
Products and Solutions Highlights
Your pursuit of better patient outcomes drives everything we do. With UNIK interconnected solutions, enhanced by tailored support services, you can elevate your MRI diagnostics at each point of the patient journey.
Liflow® by Intrasense, is an AI-enhanced oncology diagnostic and patient monitoring solution for the detection of lung and liver lesions. ECR will be the occasion to reveal a new AI DUOncoTM, developed in collaboration with Guerbet, dedicated to bone lesions.
Myrian® by Intrasense, is a multimodality medical imaging platform. Discover at ECR its AI dedicated to lung, prostate and brain pathologies (IcoBrain).
Legal informations
Myrian® software, a class IIa medical device, is developed, manufactured and distributed by Intrasense SA. Myrian is a software for processing, management, advanced visualization and analysis of multimodality medical images.This medical device is not FDA cleared, it is intended for presentation or demonstration purposes only and cannot be made available until it has been brought into compliance with US Medical Device Regulation.
Myrian® 2.13 carries the CE 0459 mark in accordance with the requirements of;regulation 745/2017 on medical devices.
As Myrian® is a medical device, non-refundable, it is intended for use by healthcare professionals only. Precautions for use must be implemented, consult instructions for use for more information.
Myrian® XP-Prostate option AI available with Myrian® 2.13 is an AI option of the variant Myrian® XP-Prostate.
Myrian® XP-LungNodule option AI available with Myrian® 2.13 is an AI option of the variant Myrian® XP-LungNodule.
Intrasense® and Myrian® are either registered trademarks or trademarks of Intrasense SA in France and/or other countries.
Intrasense - 1231 Avenue du Mondial 98 - 34 000 Montpellier (France).
Liflow® software, a class IIa medical device, is developed, manufactured and distributed by Intrasense SA. Liflow is an application dedicated to the interpretation of oncology examinations. This medical device is not FDA cleared, it is intended for presentation or demonstration purposes only and cannot be made available until it has been brought into compliance with US Medical Device Regulation.
Liflow® 2.0 carries the CE 0459 mark in accordance with the requirements of regulation 745/2017 on medical devices.
As Liflow® is a medical device, non-refundable, it is intended for use by healthcare professionals only. Precautions for use must be implemented, consult instructions for use for more information.
A new version of Liflow® 3.0 is under CE 0459 evaluation.
Intrasense® and Liflow® are either registered trademarks or trademarks of Intrasense SA in France and/or other countries.
Intrasense - 1231 Avenue du Mondial 98 - 34 000 Montpellier (France).
DUOnco™ Liver, a Class IIa medical device, is developed, manufactured and distributed by Intrasense SA. DUOnco™ Liver is software designed to facilitate the analysis and review of contrast-enhanced CT images (portal phase) containing the liver through the automatic detection and measurement of liver lesions. This medical device is not FDA-approved, is intended for display or demonstration purposes only, and cannot be made available until it has been brought into compliance with US medical device regulations.
DUOnco™ Liver bears the CE 0459 mark in accordance with the requirements of Regulation 745/2017 on medical devices. As DUOnco™ Liver is a medical device, not reimbursable, it is intended for use by healthcare professionals only. Precautions for use must be implemented, consult the instructions for use for further information.
Intrasense® and DUOnco™ are either registered trademarks or trademarks of Intrasense SA or Guerbet in France and/or other countries.
Intrasense - 1231 Avenue du Mondial 98 - 34 000 Montpellier (France).
DUOnco™ Bone and DUOnco™ Pancreas algorithms are products under development, not CE-marked, for presentation or demonstration purposes only.
E25003388
February 2025